We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1402:TWSEFar Eastern New Century Corporation Analysis

Data as of 2026-05-25 - not real-time

HK$0.28

Latest Price

8/10Risk

Risk Level: High

Executive Summary

i‑Control Holdings is trading at HK$0.275, notably above its DCF‑derived fair value of roughly HK$0.217, suggesting the market is pricing in optimism that is not yet justified by fundamentals. The stock sits just above the technical support of HK$0.265 and well under the resistance at HK$0.315, with the 20‑day SMA (HK$0.287) still higher than the current price, indicating modest upside potential, yet the MACD is bearish and the RSI at 44 points to a neutral momentum stance.
Financially, the company faces steep challenges: revenue has contracted by 27%, gross margin is a thin 7.5%, operating margin is near‑zero and net profit margin is negative 7.3%. ROE and ROA are both negative, and the balance sheet shows a modest cash buffer (HK$50.5 M) against debt (HK$8.2 M) with a high debt‑to‑equity ratio of 6.97. High 30‑day volatility (≈66%) and a historic max drawdown of 39% further underscore the risk, while the beta of essentially zero implies the stock moves independently of broader market swings.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price marginally above technical support with increasing volume
  • Bearish MACD signal and neutral RSI indicating limited upside
  • Overvaluation relative to DCF fair value

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Continued negative revenue growth and profit margins
  • High volatility and recent large drawdown
  • Valuation gap between market price and intrinsic value

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained lack of profitability and negative ROE
  • Structural overvaluation without dividend support
  • Elevated sector and geographic risks in the technology services market

Key Metrics & Analysis

Financial Health

Revenue Growth-27.00%
Profit Margin-7.30%
ROE-1.31%
ROA-0.71%
Debt/Equity6.97
P/B Ratio2.5
Op. Cash FlowHK$13.4M
Free Cash FlowHK$14.3M
Industry P/E39.5

Technical Analysis

TrendBullish
RSI44.5
SupportHK$0.26
ResistanceHK$0.31
MA 20HK$0.29
MA 50HK$0.28
MA 200HK$0.25
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair ValueHK$0.22
GradeOvervalued
TypeValue

Risk Assessment

Beta0.01
Volatility65.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.